BIIB vs BMY
Biogen Inc. · Bristol-Myers Squibb Company
Relative return (rebased to 100)
Key stats
| Metric | BIIB | BMY |
|---|---|---|
| Price | $217.15 | $63.64 |
| Market Cap | $32.06B | $130.00B |
| P/E | 24.80 | 18.43 |
| P/B | 1.72 | 5.82 |
| P/S | 3.24 | 2.70 |
| ROE | 6.9% | 31.6% |
| Net Margin | 13.1% | 14.6% |
| Gross Margin | 117.7% | 63.8% |
| Revenue Growth | 2.2% | -0.2% |
| Dividend Yield | — | 3.91% |
| EPS | $8.76 | $3.45 |
Metrics from owned fundamentals, updated daily. Highlighted values are the more favorable of the two.